These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12916755)

  • 1. Urinary monitoring method of 3,3'-dichlorobenzidine (DCB) and its metabolites, N-acetyl-DCB and N,N'-diacetyl-DCB.
    Lee JH; Shin HS; Jung DG; Lee YS
    Ind Health; 2003 Jul; 41(3):242-8. PubMed ID: 12916755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of hemoglobin adducts formed in rats exposed orally with 3,3'-dichlorobenzidine by GC/MS-SIM.
    Lee JH; Shin HS
    Toxicol Ind Health; 2002 May; 18(4):191-9. PubMed ID: 12974542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of dichlorobenzidine-hemoglobin adducts by GC/MS-NCI.
    Joppich-Kuhn R; Hänggi R; Sagelsdorff P; Smith AE; Weideli HJ; Joppich M
    Int Arch Occup Environ Health; 1997; 69(4):240-6. PubMed ID: 9137997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of bioavailability of dichlorobenzidine form diarylide azo pigments: molecular dosimetry for hemoglobin and DNA adducts.
    Sagelsdorff P; Haenggi R; Heuberger B; Joppich-Kuhn R; Jung R; Weideli HJ; Joppich M
    Carcinogenesis; 1996 Mar; 17(3):507-14. PubMed ID: 8631137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo binding of 3,3'-dichlorobenzidine to rat and mouse tissue DNA.
    Ghosal A; Iba MM
    Cancer Lett; 1990 Sep; 53(2-3):197-204. PubMed ID: 2208080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement by butylated hydroxytoluene of the in vitro activation of 3,3'-dichlorobenzidine.
    Ghosal A; Iba MM
    Mutat Res; 1992 Jan; 278(1):31-41. PubMed ID: 1370117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine monitoring of textile workers exposed to dichlorobenzidine-derived pigments.
    Hatfield TR; Roberts EC; Bell IF; Clunie JC; Kalla PJ; McKay DL
    J Occup Med; 1982 Sep; 24(9):656-8. PubMed ID: 7131106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary metabolites of 3, 3'-dichlorobenzidine and their mutagenicity (author's transl)].
    Tanaka K
    Sangyo Igaku; 1981 Jul; 23(4):426-7. PubMed ID: 7321290
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of 3,3'-dichlorobenzidine in rat liver microsomes to mutagens: involvement of cytochrome P-450d.
    Iba MM; Thomas PE
    Carcinogenesis; 1988 May; 9(5):717-23. PubMed ID: 3130202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of 3,3'-dichlorobenzidine-mediated toxicity in HepG2 cells.
    Chen LC; Wu JC; Tuan YF; Tseng YK; Hseu YC; Chen SC
    Environ Mol Mutagen; 2014 Jun; 55(5):407-20. PubMed ID: 24604609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism by rats of 2-dodecylcyclobutanone, a radiolytic compound present in irradiated beef.
    Gadgil P; Smith JS
    J Agric Food Chem; 2006 Jun; 54(13):4896-900. PubMed ID: 16787045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver and urinary bladder tumors in dogs from 3,3'-dichlorobenzidine.
    Stula EF; Barnes JR; Sherman H; Reinhardt CF; Zapp JA
    J Environ Pathol Toxicol; 1978; 1(4):475-90. PubMed ID: 722199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of possible metabolism of pigment yellow 17, a 3,3'-dichlorobenzidine-based pigment, after inhalation exposure in rats.
    Hofmann T; Schmidt D
    Arch Toxicol; 1993; 67(2):141-4. PubMed ID: 8481102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 3,3'-dichlorobenzidine by horseradish peroxidase.
    Lang B; Iba MM
    Xenobiotica; 1988 Aug; 18(8):893-904. PubMed ID: 3188570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of 3,3'-dichlorobenzidine in the rat.
    Hsu RS; Sikka HC
    Toxicol Appl Pharmacol; 1982 Jun; 64(2):306-16. PubMed ID: 7123557
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomonitoring of aromatic amines. IV: Use of hemoglobin adducts to demonstrate the bioavailability of cleavage products from diarylide azo pigments in vivo.
    Zwirner-Baier I; Neumann HG
    Arch Toxicol; 1994; 68(1):8-14. PubMed ID: 8166610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of meperidine and its metabolites in urine of an addict by gas chromatography-flame ionization detection and gas chromatography-mass spectrometry.
    Liu F; Hu X; Luo Y
    J Chromatogr B Biomed Appl; 1994 Aug; 658(2):375-9. PubMed ID: 7820266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
    Tatematsu M; Miyata Y; Mizutani M; Hananouchi M; Hirose M
    Gan; 1977 Apr; 68(2):193-202. PubMed ID: 892293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas chromatographic/tandem mass spectrometric identification and quantitation of metabolic 4-acetyltoluene-2,4-diamine from the F344 rat.
    Bartels MJ; Timchalk C; Smith FA
    Biol Mass Spectrom; 1993 Mar; 22(3):194-200. PubMed ID: 8384886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a microtiter plate enzyme immunoassay for antibodies to 3,3'-dichlorobenzidine.
    Spierto FW; Vogt R; Whitfield W; Powell MK; Gardner FH; Hannon WH
    J Anal Toxicol; 1987; 11(1):31-5. PubMed ID: 3546934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.